FindTrial
Sign In

The factors affected the use of sugammadex and the postoperative outcomes associated with its use in laparoscopic colorectal cancer surgery.

The factors affected the use of sugammadex and the postoperative outcomes associated with its use in laparoscopic colorectal cancer surgery.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004551
Enrollment
711
Registered
2019-12-12
Start date
2019-11-30
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chungnam National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who had undergone colorectal cancer surgery by our single surgeon during 2014-2018.

Exclusion criteria

Exclusion criteria: Robot surgery. Surgery performed with other surgery. Severe concomitant cardiopulmonary disease was scheduled prior to surgery. Insufficient medical records.

Design outcomes

Primary

MeasureTime frame
Factors Affecting Sugarmadex Use—

Secondary

MeasureTime frame
Postoperative Indices Caused by the Use of Sugarmadex—

Countries

Korea, Republic of

Contacts

Public ContactSeojin Sim

Chungnam National University Hospital

sseojin28@naver.com+82-42-280-7840

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026